不同靈芝菌株菌絲體乙醇提取物體外抑瘤活性的比較和機理
A COMPARISON STUDY OF THE IN VITROANTICANCER ACTIVITY AND MECHANISM OF ETHANOL EXTRACTS FROM MYCELIA OF DIFFERENT GANODERMA LUCIDUM STRAINS
楊曉彤 周月琴 李緒全 馮慧琴 糜可 楊慶堯
摘 要:以人急性早幼粒白血病細胞HL-60細胞株作為模型,用MTT法測定生長抑制率,流式細胞Annexin V實驗和DNA含量法研究抑瘤機制,比較了8個靈芝Ganodermalucidum菌株發(fā)酵菌絲體乙醇提取物的體外抗腫瘤活性和抑瘤機制.篩選結(jié)果得到了能產(chǎn)生高抑瘤活性乙醇提取物的靈芝菌株L5.其對HL-60細胞的抑制率為91.4±0.9%(72小時,125μg/mL);作用48小時后,13.3%的細胞發(fā)生早期凋亡,G0/G1期細胞比例比對照組增加15.9%,而S期細胞比例則下降了8.4%,G2/M期細胞數(shù)減少7.6%.本研究證明了靈芝菌絲體乙醇提取物能有效抑制HL-60腫瘤細胞的體外生長,抑制率與菌株相關(guān),其抑瘤機制與細胞Go/G1期阻滯和誘導凋亡有關(guān).
關(guān)鍵詞:細胞周期,凋亡,HL-60細胞
分類號:Q936 文獻標識碼:A
文章編號:1672-6472(2005)02-0251-0258
基金項目:上海市教育委員會科學項目資助(項目號04DB20)
作者簡介:楊曉彤,通訊作者:email:xtyang@shnu.edu.cn
作者單位:楊曉彤(上海師范大學微生物與免疫學研究所,上海,200234)
周月琴(上海師范大學微生物與免疫學研究所,上海,200234)
李緒全(上海師范大學微生物與免疫學研究所,上海,200234)
馮慧琴(上海師范大學微生物與免疫學研究所,上海,200234)
糜可(上海師范大學微生物與免疫學研究所,上海,200234)
楊慶堯(上海師范大學微生物與免疫學研究所,上海,200234)
參考文獻:
[1]Cai H, Wang FS, Wang LF, Bai Y, Xu L, Yang JS, Zhang YM, 2001. Method of determination of content of biological activity constituents ganoderic acid in Ganoderma lucidum. Chinese Journal of Veterinary Science, 21(4): 381~383 (in Chinese)
[2]Chen RY, Yu DQ, 1990. Progress of studies on chemical constituents of Ganoderma lucidum. Acta Pharmaceutica Sinica,25 (12): 940~953 (in Chinese)
[3]Fang QH, Zhong JJ, 2002. Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum. Biotechnol. Progr, 18:51~54
[4]Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK, Hattori M, 2002. New titerpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull, 50 (6): 867~940
[5]Gonzalez AG, Leon F, Rivera A, Padron JI, Gonzalez-Plata J, Zuluaga JC, Quintana J, Estevez F, Bermejo J, 2002. New lanostanoids from the fungus Ganoderma concinna. J Nat Prod, 5:417~421
[6]Gu J, 2002. Extraction of ganoderic acid from Ganoderma lucidum by using ultrasonic assistance. Journal of Nantong Institute of Technology (Natural Science), 1(3):13~16 (in Chinese)
[7]Hirotani M, Furuya T, 1990. Changes of the triterpene patterns during formation of the fruiting body in Ganoderma lucidum.Phytochemistry, 29:3767~3771
[8]Hu H, Ahn NS, Yang XL, Lee YS, Kang KS, 2002. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Iht J Cancer, 102:250~253
[9]Jong SC, Birmingham JM, 1992. Medicinal benefits of the mushroom Ganoderma. Adv Appl Microbiol, 37:101~34
[10]Kimura Y, Taniguchi M, Baba K, 2002. Antitumor and antimetastic effects on liver triterpene fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res, 22 (6A): 3309~3318
[11]Kohda H, Tokumoro W, Sakamoto K, Fuiji M, Hirai Y, Yamasaki K, Komada Y, Nakamura H, Ishihara S, Uchida M, 1985. The biologically active constituents of Ganoderma lucidum (Fr.) Karst. histamine release-inhibitory triterpenes. Chem Pharm Bull,33(4): 1367~1374
[12]Li PZ, Xu R, Xia JH, Zhang KC, 2000. Production of teracyclic triterpene acids by submerged fermentation of Ganoderma lucidum.Industrial Microbiology, 20 (1): 15~17 (in Chinese)
[13]Lin SB, Li CH, Lee SS, Kan LS, 2003. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sciences, 72:2381~2390
[14]Lin ZB, Zhang HN, 2004. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharm Sin, 25 (11): 1387~1395
[15]Luo J, Lin ZB, 2002. Advances of pharmacological effects of triterpenes from Ganoderma lucidum. Acta Pharm Sin, 37 (7): 574~578(in Chinese)
[16]Ma L, Wu F, Chen RY, 2003. Analysis of triterpene constituents from Ganoderma lucidum. Acta Pharm Sin, 38 (1): 50~52 (in Chinese)
[17]Min BS, Gao JJ, Nakamura N, Hattori M, 2000. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull, 48 (7): 1026~1033
[18]Mosmann T, 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 65:55~63
[19]Nishitoba T, Sato H, Kasai T, Kawagishi H, Sakamura S, 1985. New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). Agric Biol Chem, 49:1793~1798
[20]Ranynal P, Pollard HB, 1994. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium and phospholipid-binding protein. Biochemica et Biophysica Acta, 1197: 63~93.
[21]Sliva D, 2003. Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther, 2(4): 358~364
[22]Toth JO, Luu B, Ourisson GL, 1983. Acides ganoderiques T a Z: triterpenes cytotoxiques de Ganoderma lucidum (Polyporaceae).Terahedr Lett, 24:1081~1084
[23]Vindelov LL, 1977. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspension.Virchows-Arch-B-Cell-Pathology, 24 (3): 227~242
[24]Wang WX, Gu ZL, 2001. Colorimetric detection of total triterpene content in Crataegus pinnatifida. China Wilding Resources,20 (5): 47~48 (in Chinese)
[25]Wu TS, Shi LS, Kuo SC, 2001. Cytotoxicity ofGanoderma lucidum triterpenes. JNatProd, 64:1121~1122
[26]Xiang SP, Tang HC, Chen G, Shi YS, 2001. Studied on colorimetric determination of oleanolic acid in Chinese quince. Natural Product Research and Development, 13 (4): 23~26 (in Chinese)
[27]Zhu HS, Yang XL, Wang LB, Zhao DX, Chen L, 2000. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on Hela cells. Cell Biol Toxicol, 16:201~206
[28]陳若蕓,于德泉,1990.靈芝三萜化學成分研究進展.藥學學報,25(12):940~953
[29]羅俊,林志彬,2002.靈芝三萜化合物藥理作用研究進展.藥學學報,37(7):574~578
[30]顧劍,2002.利用超聲輔助從培養(yǎng)的靈芝中提取靈芝酸.南通工學院學報,1 (3):13~16
[31]王文祥,顧振綸,2001.比色法測定山渣總?cè)扑岬暮?中國野生植物資源,20(5):14~48
[32]項昭保,唐春紅,2001.木瓜中齊墩果酸測定方法的研究.天然產(chǎn)物研究與開發(fā),13(4):23~26
[33]蔡輝,王芳生,王麗鳳,白燕,許莉,楊峻山,張津梅,2001.赤芝中靈芝酸類生物活性成分含量的測定方法.中國獸醫(yī)學報,21(4):381~383
[34]馬林,吳豐,陳若蕓,2003.靈芝三萜成分分析.藥學學報,1:50~52
[35]李平作,徐柔,夏結(jié)紅,章克昌,2000.靈芝深層發(fā)酵生產(chǎn)四環(huán)三萜酸的研究.工業(yè)微生物,30(1):15~17
菌物學報
MYCOSYSTEMA
2005 Vol.24 No.2 P.251-258